19 August 2022: Original Paper
Risk Factors for Erythrocytosis in Renal Transplantation: Is Ganciclovir Therapy One of Them?
Fatma Özge Kayhan Koçak 1ABCDEF* , Musa Bali 2ADEFDOI: 10.12659/AOT.936814
Ann Transplant 2022; 27:e936814
Table 2 Multivariate logistic regression analysis of factors predicting development of post-transplant erythrocytosis.
| Post-transplant erythrocytosis | ||
|---|---|---|
| OR (95% CI) | P value | |
| Male sex | 0.163 (0.054–0.496) | 0.01 |
| Living donor | 2.845 (1.043–7.756) | 0.041 |
| Ganciclovir | 1.51 (0.694–3.284) | 0.298 |
| Hypertension | 3.508 (1.22–10.085) | 0.02 |
| 95% CI – 95% confidence interval. | ||